𝔖 Bobbio Scriptorium
✦   LIBER   ✦

PCN48 SUNITINIB MALATE PROVIDES ADDITIONAL SURVIVAL AND VALUE FOR MONEY AS A SECOND LINE TREATMENT FOR METASTATIC RENAL CELL CARCINOMA (MRCC)—AN ECONOMIC EVALUATION USING BAYESIAN APPROACH

✍ Scribed by T Purmonen; JA Martikainen; EJ Soini; V Kataja; P Kellokumpu-Lehtinen


Book ID
119596067
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
70 KB
Volume
10
Category
Article
ISSN
1098-3015

No coin nor oath required. For personal study only.